JERALYNN SHEETS: Open Payments
NPI 1487356622 · GROVE CITY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 34 payments from 16 companies in 2025. Trend: 2023 $452 · 2024 $1,178 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $117 |
| Novo Nordisk Inc | 4 | $72 |
| Dexcom, Inc. | 3 | $72 |
| Lilly USA, LLC | 3 | $57 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Abbott Laboratories | 2 | $41 |
| PFIZER INC. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
Products named: Dexcom G6 Transmitter, VRAYLAR, Ozempic, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, MOUNJARO, ELIQUIS, REXULTI.
Industry payments across OH — which companies pay providers there.
